Laurel Lee stock trades
Laurel Lee, the representative for FL-15, filed 6 periodic transaction reports in 2025 and 2026, disclosing 11 stock trades we could read: 2 purchases and 9 sales, worth between $222.0K and $605.0K in total.
Disclosed stock trades
| Traded | Stock | Type | Amount | Owner | Filed |
|---|---|---|---|---|---|
| Aug 24, 2026 | BACBank of America | Sell | $50,001 – $100,000 | Spouse | Oct 16 ↗ |
| Jul 06, 2026 | NOKNOKIA CORP | Sell · option | $1,001 – $15,000 | Spouse | Jul 19 ↗ |
| Jul 06, 2026 | NOKNOKIA CORP | Sell · option | $1,001 – $15,000 | Spouse | Jul 19 ↗ |
| Jun 16, 2026 | GEGE Aerospace | Sell · option | $1,001 – $15,000 | Spouse | Jul 19 ↗ |
| Jun 02, 2026 | BACBank of America | Sell (partial) | $1,001 – $15,000 | Spouse | Jul 19 ↗ |
| Jun 02, 2026 | NOKNOKIA CORP | Sell (partial) | $1,001 – $15,000 | Spouse | Jul 19 ↗ |
| May 11, 2026 | NOKNOKIA CORP | Sell (partial) | $15,001 – $50,000 | Spouse | Jul 19 ↗ |
| Dec 29, 2023 | BABAAlibaba Group Holding Ltd | Sell | $100,001 – $250,000 | Spouse | Aug 11 ↗ |
| Jul 13, 2025 | HURATuHURA Biosciences, Inc./NV | Buy | $50,001 – $100,000 | Spouse | Aug 09 ↗ |
| May 08, 2025 | NVONOVO NORDISK A S | Sell (partial) | $1,001 – $15,000 | Spouse | Jun 22 ↗ |
| Nov 25, 2024 | HURATuHURA Biosciences, Inc./NV | Buy | $1,001 – $15,000 | Spouse | Jan 07 ↗ |
Owner is shown when the form marks it (Spouse, Joint, Child); — means the member or not marked.
Frequently asked questions
What stocks has Laurel Lee traded recently?
The most recent disclosed trade is a sell of BAC (Bank of America) on 2026-08-24, valued at $50,001 – $100,000, reported on 2026-10-16. Most traded: NOK (4), BAC (2), HURA (2), GE (1), BABA (1).
Are these trades made by the member personally?
Not always. The reports cover the member, their spouse and dependent children; where the form marks the owner (SP = spouse, JT = joint, DC = dependent child), we show it. Read the original PDF for every detail, including descriptions of option trades.
Source: Periodic Transaction Reports filed with the Office of the Clerk, U.S. House of Representatives, read automatically; only fully validated stock and stock-option trades are listed. Public disclosure data, not a recommendation.